AliquantumRx Inc.’s patent Salts and Polymorphs of Cethromycin for the Treatment of Bacterial and Protozoan Disease approved in Japan

AliquantumRx Inc., a Johns Hopkins FastForward company supported by Maryland Technology Development Corporation (TEDCO) is proud to announce the approval of its patent “Salts and Polymorphs of Cethromycin for the Treatment of Bacterial and Protozoan Disease” in Japan. The Japanese patent number is 7693669.